文献速递生殖医学产科

重新审视促甲状腺激素与甲状腺自身免疫对妊娠结局的相关性:基于多囊卵巢综合征妊娠研究和卵巢刺激多胎妊娠评估随机对照试验数据的分析

A relook at the relevance of thyroid stimulating hormone and thyroid autoimmunity for pregnancy outcomes: Analyses of randomized control trials data from Pregnancy in Polycystic Ovary Syndrome and Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation.
PubMed 文献 · Fertil Steril · 2024-12-12

该研究回顾性分析了PCOS(PPCOS II,n=746)和不明原因不孕(AMIGOS,n=832)两项RCT数据,探讨甲状腺自身免疫是否影响母亲TSH水平与妊娠结局的关系。暴露组(TSH≥2.0 mU/L且TPO-Ab≥30 U/mL,n=117/1,578)活产率显著低于非暴露组(ARR 0.55,95%CI 0.35-0.87),流产和早期早产风险显著升高。作者认为在TPO-Ab≥30 U/mL女性中,TSH≥2 mU/L时妊娠结局可能受损,此交互作用需前瞻性研究进一步探讨。

要点

  • 在TPO-Ab≥30 U/mL女性中,TSH≥2.0 mU/L时活产率较非暴露组显著降低(ARR 0.55)。
  • 暴露组流产风险显著升高(ARR 1.66,95%CI 1.14-2.42)。
  • 暴露组早期早产(<32周)风险显著升高(ARR 4.82,95%CI 1.53-15.19)。

核心结论

  • 在TPO-Ab滴度≥30 U/mL的女性中,TSH阈值≥2 mU/L时妊娠结局可能受损;TSH与TPO对妊娠结局的交互作用需在前瞻性研究中进一步探讨。

研究设计与样本

  • 回顾性队列分析,数据来自两项随机对照试验:PCOS妊娠研究(PPCOS II,n=746)和卵巢刺激多胎妊娠评估研究(AMIGOS,n=832,不明原因不孕)。

主要发现

  • 调整分析中,暴露组(TSH≥2.0 mU/L且TPO-Ab≥30 U/mL,n=117/1,578,7.4%)活产显著低于非暴露组(TSH<2.0 mU/L且TPO-Ab<30 U/mL,n=865/1,578,54.8%),ARR 0.55(95%CI 0.35-0.87)。
  • 暴露组流产风险显著高于非暴露组,ARR 1.66(95%CI 1.14-2.42)。
  • 暴露组早期早产(<32周)风险显著高于非暴露组,ARR 4.82(95%CI 1.53-15.19)。
  • 分析调整了年龄、体质指数、种族、民族、教育、吸烟、不孕时长、PCOS(相对于不明原因不孕)及各自RCT中的随机干预组。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出这些发现需在前瞻性研究中进一步探讨。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We examined if thyroid autoimmunity is relevant to the relationship between maternal thyroid stimulating hormone (TSH) levels and pregnancy outcomes. DESIGN: Retrospective cohort analysis of data from 2 randomized controlled trials (RCTs). SUBJECTS: Participants of the Pregnancy in Polycystic Ovary Syndrome (PPCOS II, n = 746) and the Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation (AMIGOS, n = 832 with unexplained infertility) RCTs. EXPOSURE: Pre-RCT intervention levels of TSH at threshold of ≥2.0 mU/L and thyroid peroxidase antibody (TPO-Ab) at titer threshold of ≥30 U/mL. MAIN OUTCOME MEASURES: Live birth (primary outcome), pregnancy loss, and preterm birth (secondary outcomes). Generalized linear model (GLM) analyses examined the relationship between exposure to TSH and TPO-Ab at specified thresholds with the specified outcomes; covariates adjusted for included age, body mass index, race, ethnicity, education, smoking, duration of infertility, PCOS (vs. unexplained infertility), and randomized intervention arm in the respective RCTs. RESULTS: On adjusted analyses, live birth was significantly reduced in the exposed population (those with TSH ≥2.0 mU/L and TPO-Ab ≥30 U/mL, n = 117/1,578, 7.4%, adjusted risk ratio [ARR]: 0.55; 95% CI: 0.35-0.87) compared with the unexposed (those with TSH <2.0 mU/L and TPO-Ab <30 U/mL, n = 865/1,578, 54.8%). Furthermore, the risk of pregnancy loss and of early preterm birth (<32 weeks) was significantly higher in the exposed compared with the unexposed (ARR for pregnancy loss was 1.66; 95% CI: 1.14-2.42, and ARR for early preterm birth was 4.82, 95% CI: 1.53-15.19). CONCLUSION: In women with TPO-Ab titers ≥30 U/mL, pregnancy outcomes may be compromised at TSH threshold of ≥2 mU/L. These findings of an interaction between TSH and TPO for pregnancy outcomes merit further investigation in prospective studies. TRIAL REGISTRATION NUMBER: NCT00719186 and NCT01044862.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Kuokkanen S, Seungdamrong A, Santoro N, et al. A relook at the relevance of thyroid stimulating hormone and thyroid autoimmunity for pregnancy outcomes: Analyses of randomized control trials data from Pregnancy in Polycystic Ovary Syndrome and Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation. Fertil Steril. 2024. PMID: 39672366. doi:10.1016/j.fertnstert.2024.12.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。